{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T20:24:55Z","timestamp":1768595095372,"version":"3.49.0"},"reference-count":43,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Jie Du Center for Innovation and Excellence for Drug Development","award":["#D30022"],"award-info":[{"award-number":["#D30022"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The targeting of cyclin dependent kinase 8 (CDK8) as a potential strategy for cancer treatment has been of interest since the identification of CDK8 as an oncogene product. In this report, we communicate the results of our continuing investigation into the effects of CDK8 inhibitor on triple-negative breast cancer cell line MDA-MB-468. Here, we demonstrate that inhibition of CDK8 decreases phosphorylation of CDK8 substrates E2 promoter binding factor 1 (E2F1) at serine 375 and signal transducer and activator of transcription 3 (STAT3) at serine 727 in these cells. Additionally, luciferase expression was increased in E2F1-responsive luciferase plasmid-transfected cells. Expression of E2F1 transcription target, the proapoptotic protein p73, was increased, and expression of antiapoptotic protein myeloid cell leukemia sequence 1 (Mcl-1) was decreased in CDK8 inhibitor-treated cells. We also demonstrate that knockdown of STAT3 or disruption of STAT3 function in MDA-MB-468 cells opposes the effects of CDK8 inhibition on Mcl-1. Together, these results suggest that CDK8 inhibitor treatment can modulate the expression of apoptosis-related proteins p73 and Mcl-1 and continues to highlight the potential cooperative effects of E2F1 and STAT3 in the activity of CDK8 inhibitor against MDA-MB-468 triple-negative breast cancer cells.<\/jats:p>","DOI":"10.3390\/ijms27020897","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:08:21Z","timestamp":1768550901000},"page":"897","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CDK8 Inhibition Increases E2F1 Transcriptional Activity and Promotes STAT3-Dependent Suppression of Mcl-1 in Triple-Negative Breast Cancer Cell Line MDA-MB-468"],"prefix":"10.3390","volume":"27","author":[{"given":"Sandra","family":"Do","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Thomas J. Long School of Pharmacy, University of the Pacific, Stockton, CA 95211, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengxi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Thomas J. Long School of Pharmacy, University of the Pacific, Stockton, CA 95211, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Thomas J. Long School of Pharmacy, University of the Pacific, Stockton, CA 95211, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9676-0712","authenticated-orcid":false,"given":"Jensen M.","family":"Spear","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Thomas J. Long School of Pharmacy, University of the Pacific, Stockton, CA 95211, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhixin","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Thomas J. Long School of Pharmacy, University of the Pacific, Stockton, CA 95211, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William K.","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Thomas J. Long School of Pharmacy, University of the Pacific, Stockton, CA 95211, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wade A.","family":"Russu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Thomas J. Long School of Pharmacy, University of the Pacific, Stockton, CA 95211, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/trns.1.1.12373","article-title":"CDK8 A positive regulator of transcription","volume":"1","author":"Galbraith","year":"2010","journal-title":"Transcription"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"113043","DOI":"10.1016\/j.ejmech.2020.113043","article-title":"Angel or Devil ?\u2014CDK8 as the new drug target","volume":"213","author":"Wu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.bbagrm.2013.04.010","article-title":"Emerging roles of Cdk8 in cell cycle control","volume":"1829","author":"Szilagi","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nsmb.2549","article-title":"A conserved mediator\u2013CDK8 kinase module association regulates mediator\u2013RNA polymerase II interaction","volume":"20","author":"Tsai","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1101\/gad.1767009","article-title":"The human CDK8 subcomplex is a molecular switch that controls Mediator coactivator function","volume":"23","author":"Knuesel","year":"2009","journal-title":"Genes Dev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1038\/onc.2012.364","article-title":"CDK8 regulates E2F1 transcriptional activity through S375 phosphorylation","volume":"32","author":"Zhao","year":"2013","journal-title":"Oncogene"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.immuni.2012.10.017","article-title":"CDK8 kinase phosphorylates transcription factor STAT1 to selectively regulate the interferon response","volume":"38","author":"Bancerek","year":"2013","journal-title":"Immunity"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1128\/MCB.00993-08","article-title":"The human CDK8 subcomplex is a histone kinase that requires Med12 for activity and can function independently of mediator","volume":"29","author":"Knuesel","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"7899","DOI":"10.1158\/0008-5472.CAN-09-1704","article-title":"Revving the Throttle on an Oncogene: CDK8 Takes the Driver Seat","volume":"69","author":"Firestein","year":"2009","journal-title":"Cancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature07179","article-title":"CDK8 is a colorectal cancer oncogene that regulates \u03b2\u2013catenin activity","volume":"455","author":"Firestein","year":"2008","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nature07310","article-title":"E2F1 represses \u03b2-catenin transcription and is antagonized by both pRb and CDK8","volume":"455","author":"Morris","year":"2008","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"33779","DOI":"10.18632\/oncotarget.16810","article-title":"SEL120-34A is a novel CDK8 inhibitor active in AML cells with high levels of serine phosphorylation of STAT1 and STAT5 transactivation domains","volume":"8","author":"Rzymski","year":"2017","journal-title":"Oncotarget"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/nature09590","article-title":"The histone variant macroH2A suppresses melanoma progression through regulation of CDK8","volume":"468","author":"Kapoor","year":"2010","journal-title":"Nature"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1158\/1078-0432.CCR-16-0094","article-title":"Pan-cancer analysis of the mediator complex transcriptome identifies CDK19 and CDK8 as therapeutic targets in advanced prostate cancer","volume":"23","author":"Bragelmann","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"12558","DOI":"10.18632\/oncotarget.14894","article-title":"Inhibition of CDK8 mediator kinase suppresses estrogen dependent transcription and the growth of estrogen receptor positive breast cancer","volume":"8","author":"McDermott","year":"2017","journal-title":"Oncotarget"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.4161\/cc.9.6.10990","article-title":"Absence of pRb facilitates E2F1-induced apoptosis in breast cancer cells","volume":"9","author":"Sun","year":"2010","journal-title":"Cell Cycle"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Spear, J.M., Lu, Z., and Russu, W.A. (2020). Pharmacological inhibition of CDK8 in triple negative breast cancer cell line MDA-MB-468 increases E2F1 protein, induces phosphorylation of STAT3 and apoptosis. Molecules, 25.","DOI":"10.3390\/molecules25235728"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.ejmech.2011.02.057","article-title":"Discovery, Synthesis, and Investigation of the Antitumor Activity of Novel Piperazinylpyrimidine Derivatives","volume":"46","author":"Shallal","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.bbapap.2015.05.011","article-title":"CDK8 Kinase\u2014An emerging target in targeted cancer therapy","volume":"1854","author":"Ryzmski","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.neo.7900237","article-title":"The human p73 promoter: Characterization and identification of functional E2F binding sites","volume":"4","author":"Seelan","year":"2002","journal-title":"Neoplasia"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Tophkhane, C., Yang, S.-H., Jiang, Y., Ma, Z., Subramaniam, D., Anant, S., Yogosawa, S., Sakai, T., Liu, W.-G., and Edgerton, S. (2012). p53 inactivation upregulates p73 expression through E2F-1 mediated transcription. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0043564"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"108545","DOI":"10.1016\/j.celrep.2020.108545","article-title":"CDK8 Fine-Tunes IL-6 Transcriptional Activities by Limiting STAT3 Resident Time at the Gene Loci","volume":"33","author":"Wang","year":"2020","journal-title":"Cell Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-2443.2011.01575.x","article-title":"Phospho-Ser727 of STAT3 regulates STAT3 activity by enhancing dephosphorylation of phospho-Tyr705 largely through TC45","volume":"17","author":"Wakahara","year":"2012","journal-title":"Genes Cells"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1073\/pnas.90.8.3516","article-title":"Mcl-1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2","volume":"90","author":"Kozopas","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/sj.onc.1205157","article-title":"Direct repression of Mcl-1 promotor by E2F1","volume":"21","author":"Croxton","year":"2002","journal-title":"Oncogene"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1182\/blood-2002-11-3396","article-title":"Serine phosphorylation of STAT3 is essential for Mcl-1 expression and macrophage survival","volume":"102","author":"Liu","year":"2003","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.molonc.2007.02.004","article-title":"The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression","volume":"1","author":"Kenny","year":"2007","journal-title":"Mol. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1101\/gad.12.15.2245","article-title":"The regulation of E2F1 by pRb-family proteins","volume":"12","author":"Dyson","year":"1998","journal-title":"Gens. Dev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1073\/pnas.94.6.2221","article-title":"Regulation of E2F through ubiquitin-proteasome-dependent degradation: Stabilization by the pRB tumor suppressor protein","volume":"94","author":"Campanero","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5316","DOI":"10.1038\/s41598-019-41472-y","article-title":"The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors","volume":"9","author":"Tormo","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.yexcr.2017.04.016","article-title":"EGFR-mediated apoptosis via STAT3","volume":"356","author":"Jackson","year":"2017","journal-title":"Exp. Cell Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1158\/0008-5472.CAN-08-2575","article-title":"Cryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cells","volume":"69","author":"Shin","year":"2009","journal-title":"Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ccr.2006.03.027","article-title":"Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members","volume":"9","author":"Certo","year":"2006","journal-title":"Cancer Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s41419-020-03068-7","article-title":"MCL1 binds and negatively regulates the transcriptional function of tumor suppressor p73","volume":"11","author":"Widden","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"eaam7049","DOI":"10.1126\/scitranslmed.aam7049","article-title":"Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancer","volume":"9","author":"Merino","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejmech.2018.11.076","article-title":"CDK8 as a therapeutic target for cancers and recent developments in discovery of CDK8 inhibitors","volume":"164","author":"Xi","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1158\/1535-7163.MCT-24-0593","article-title":"Inhibition of MCL-1 and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers","volume":"24","author":"Mughees","year":"2025","journal-title":"Mol. Cancer Ther."},{"key":"ref_38","first-page":"32","article-title":"MiRNA-107 inhibits proliferation and migration by targeting CDK8 in breast cancer","volume":"7","author":"Li","year":"2014","journal-title":"Int. J. Clin. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41419-017-0035-2","article-title":"MCL-1 is a prognostic indicator and drug target in breast cancer","volume":"9","author":"Campbell","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1080\/15384101.2022.2054096","article-title":"Mcl-1 is a clinically targetable vulnerability in breast cancer","volume":"21","author":"Winder","year":"2022","journal-title":"Cell Cycle"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1038\/s41418-021-00773-4","article-title":"Breast cancer dependence on MCL-1 is due to its canonical anti-apoptotic function","volume":"28","author":"Campbell","year":"2021","journal-title":"Cell Death Differ."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e2414501121","DOI":"10.1073\/pnas.2414501121","article-title":"Mediator kinase inhibitors suppress triple-negative breast cancer growth and extend tumor suppression by mTOR and AKT inhibitors","volume":"121","author":"Ding","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_43","first-page":"6607","article-title":"Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter","volume":"14","author":"Neuman","year":"1994","journal-title":"Mol. Cell. Biol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/2\/897\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:10:51Z","timestamp":1768551051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/2\/897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["ijms27020897"],"URL":"https:\/\/doi.org\/10.3390\/ijms27020897","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]}}}